VIAL-INHBE | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

4,249 results for “VIAL-INHBE”

Trials

View all 3633 →

A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus

180 participants · First posted Nov 22, 2024

Evaluate Bioequivalence of Micafungin (50mg/Vial)

14 participants · First posted Aug 11, 2022

Evaluate Bioequivalence of Voriconazole(200mg/Vial) .

14 participants · First posted Sep 17, 2020

Drugs

View all 218 →

INHBE

ARO-INHBE

GalNAc-conjugated small interfering RNA targeting INHBE

Organizations

View all 15 →

VICAL

France

The Dial Corporation

United States

Vital Therapies, Inc.

United States

News

View all 383 →

Vial Initiates Phase 1 Trial of Novel INHBE siRNA Therapy for Obesity Treatment

Rona Therapeutics Files IND for RN3161, Novel siRNA Targeting INHBE for Obesity Treatment

Arrowhead Initiates Phase I/IIa Trial of RNAi Therapy ARO-INHBE for Obesity

Page 1 of 425